A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors

Conditions:   Advanced or Metastatic Solid Tumors;   Head and Neck Squamous Cell Carcinoma;   Non-Small Cell Lung Cancer;   Ovarian Cancer
Intervention:   Drug: NC318
Sponsor:   NextCure, Inc.
Not yet recruiting

https://ift.tt/2x91xKW